Patients considering tirzepatide for metabolic health should undergo appropriate lipid assessment before and during treatment
10.1126/science.1096284 Science 129 VanderkuurJ
Wang X, Ying T, Yuan J, Wang Y, Su X, Chen S, et al
The second is the conditional 6-month money-back guarantee, which requires 24 consecutive weekly doses, under 5% weight loss, a starting BMI of 30+, joining after March 14, 2026, and several additional conditions verified through submitted weight records
Measurement of F2-isoprostane levels in MASLD patients can provide valuable information about the severity and progression of the disease
Horowitz M, Aroda VR, Han J, Hardy E, Rayner CK